Fisher Asset Management
CPRX

Fisher Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Fisher Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-82,169
Closed -$2.03M – 1051
2026
Q1 		$2.03M Sell
82,169
-663
-0.8% -$15.8K ﹤0.01% 572
2025
Q4 		$1.93M Sell
82,832
-305
-0.4% -$6.79K ﹤0.01% 562
2025
Q3 		$1.64M Hold
83,137
– – ﹤0.01% 610
2025
Q2 		$1.8M Buy
83,137
+969
+1% +$22.9K ﹤0.01% 590
2025
Q1 		$1.99M Sell
82,168
-4,679
-5% -$105K ﹤0.01% 581
2024
Q4 		$1.81M Buy
86,847
+50
+0.1% +$1.07K ﹤0.01% 593
2024
Q3 		$1.73M Sell
86,797
-18,738
-18% -$347K ﹤0.01% 604
2024
Q2 		$1.63M Sell
105,535
-7,084
-6% -$110K ﹤0.01% 617
2024
Q1 		$1.8M Buy
112,619
+955
+0.9% +$14.4K ﹤0.01% 609
2023
Q4 		$1.88M Hold
111,664
– – ﹤0.01% 599
2023
Q3 		$1.31M Hold
111,664
– – ﹤0.01% 694
2023
Q2 		$1.5M Hold
111,664
– – ﹤0.01% 700
2023
Q1 		$1.85M Sell
111,664
-21,904
-16% -$361K ﹤0.01% 668
2022
Q4 		$2.48M Sell
133,568
-157,329
-54% -$2.42M ﹤0.01% 613
2022
Q3 		$3.73M Hold
290,897
– – ﹤0.01% 491
2022
Q2 		$2.04M Buy
290,897
+30,429
+12% +$223K ﹤0.01% 533
2022
Q1 		$2.16M Sell
260,468
-5,084
-2% -$35.9K ﹤0.01% 541
2021
Q4 		$1.8M Buy
265,552
+63,751
+32% +$419K ﹤0.01% 575
2021
Q3 		$1.07M Buy
+201,801
New +$1.1M ﹤0.01% 607

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management's CPRX Position: Q2 2026 in Review

Fisher Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 82,169 shares — an estimated $2.03M sold.

Fisher Asset Management first reported a position in CPRX in Q3 2021 and held it in 19 quarters. The position peaked at $3.73M in Q3 2022. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Fisher Asset Management reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Fisher Asset Management sold 82,169 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.03M.
  • Fisher Asset Management first reported a position in Catalyst Pharmaceutical in Q3 2021 and held it in 19 quarters.
  • Fisher Asset Management's Catalyst Pharmaceutical position peaked at $3.73M in Q3 2022.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.